References
- Bruix J, Boix L, Sala M, et al (2004). Focus on Hepatocellular carcinoma. Cancer Cell, 5, 215-9. https://doi.org/10.1016/S1535-6108(04)00058-3
- Bruix J, Sala M, Llovet JM (2004). Chemoembolization for hepatocellular carcinoma. Gastroenterol, 127, S179-88. https://doi.org/10.1053/j.gastro.2004.09.032
- Calle EE, Rodriguez C, Walker-Thurmond K, et al (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 348, 1625-38. https://doi.org/10.1056/NEJMoa021423
- Carr BI, Guerra V, Steel JL, et al (2015). A Comparison of Patients With Hepatitis B- or Hepatitis C-Based Advanced-Stage Hepatocellular Carcinoma. Semin Oncol, 42, 309-315. https://doi.org/10.1053/j.seminoncol.2014.12.019
- Dai XZ, Yin HT, Sun LF, et al (2013). Potential therapeutic efficacy of curcumin in liver cancer.Asian Pac J Cancer Prev, 14, 3855-9. https://doi.org/10.7314/APJCP.2013.14.6.3855
- Fattovich G, Stroffolini T, Zagni I, et al (2004). Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterol, 127, S35-50. https://doi.org/10.1053/j.gastro.2004.09.014
- Graf D, Vallbohmer D, Knoefel WT, et al (2014). Multimodal treatment of hepatocellular carcinoma. Eur J Intern Med, 25, 430-7. https://doi.org/10.1016/j.ejim.2014.03.001
- Jeng JE, Tsai MF, Tsai HR, et al (2014). Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis inhepatocellular carcinoma related to betel quid chewing. Asian Pac J Cancer Prev, 15, 637-42. https://doi.org/10.7314/APJCP.2014.15.2.637
- Kar P (2014). Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol, 4, S34-42.
- Kim MN, Han KH, Ahn SH (2015). Prevention of Hepatocellular Carcinoma: Beyond Hepatitis B Vaccination. Semin Oncol, 42, 316-28. https://doi.org/10.1053/j.seminoncol.2014.12.018
- Li X, Zhong X, Chen ZH, et al (2014). Hepatitis B virus DNA negativity acts as a favorable prognostic factor inhepatocellular carcinoma patients. Asian Pac J Cancer Prev, 15, 9635-41. https://doi.org/10.7314/APJCP.2014.15.22.9635
- Liu Y, Xie L, Zhao J, Huang X, et al (2015). Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in guangxi population: a case-control study. Medicine, 94, e702. https://doi.org/10.1097/MD.0000000000000702
- Maida M, Orlando E, Camma C, et al (2014). Staging systems of hepatocellular carcinoma: a review of literature. World J Gastroenterol, 20, 4141-50. https://doi.org/10.3748/wjg.v20.i15.4141
- Morise Z, Kawabe N, Tomishige H, et al (2014). Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol, 20, 14381-92. https://doi.org/10.3748/wjg.v20.i39.14381
- Norsa'adah B, Nurhazalini-Zayani CG (2013). Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia. Asian Pac J Cancer Prev, 14, 6955-9. https://doi.org/10.7314/APJCP.2013.14.11.6955
- Oyunsuren T, Sanduijav R, Davaadorj D, et al (2006). Hepatocellular carcinoma and its early detection by AFP testing in Mongolia. Asian Pac J Cancer Prev, 7, 460-2.
- Poon RT, Fan ST, Ng IO, et al (2000). Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical. Ann Surg, 231, 544-51. https://doi.org/10.1097/00000658-200004000-00014
- Ramesh H (2014). Resection for hepatocellular carcinoma. J Clin Exp Hepatol, 4, S90-6.
- Yamamoto Y, Ikoma H, Morimura R, et al (2015). Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy. World J Gastroenterol, 21, 1207-15. https://doi.org/10.3748/wjg.v21.i4.1207
- Xu C, Lv PH, Huang XE, et al (2014). Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC.Asian Pac J Cancer Prev, 15, 703-6. https://doi.org/10.7314/APJCP.2014.15.2.703
- Yang X, Gao JY, Wang J, et al (2015). The impact of anti-HBV treatment on the occurrence and Recurrence ofhepatocellular carcinoma: focus on Asian studies. Discov Med, 19, 89-99.
- Zhu WJ, Huang CY, Li C, et al (2013). Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting Milan criteria after curative resection. Asian Pac J Cancer Prev, 14, 7101-6. https://doi.org/10.7314/APJCP.2013.14.12.7101
Cited by
- Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis vol.10, pp.10, 2015, https://doi.org/10.1371/journal.pone.0140067